Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 203, Issue 5, Pages 595-601Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiq098
Keywords
-
Categories
Funding
- H. W. and J. Hector Foundation [M42]
- BMBF (German Ministry for Science and Education) [01KI0791]
Ask authors/readers for more resources
Recently, a IL28B (rs 12979860) gene polymorphism was identified as a predictor for response to hepatits C virus-specific treatment in human immunodeficiency virus (HIV)-uninfected and -infected patients with chronic hepatitis C. In an analysis of HIV-infected patients with acute hepatitis C, we found that the IL28B genotype was associated with serum levels of hepatitis C virus RNA, g-GT, and CD4 cell count. In contrast to HIV-infected patients with chronic hepatitis C, the IL28B genotype was not significantly associated with treatment response rates in patients with acute hepatitis C. Thus, effects of the IL28B single-nucleotide polymorphism may differ in HIV-infected patients with chronic and acute hepatitis C.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available